Janssen To Change Name Of Reminyl Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Janssen agreed to change the brand name for galantamine products due to continued confusion with Aventis' Amaryl, which has resulted in medication errors. The company will submit new proposed names to FDA for review.